Patient-Derived Xenograft (PDX) in Humanized Mice
PDX Studies
- Partnership with Champions Oncology: TransCure becomes the European hub and operational center
- Large cohort (> 1,000 patient tumors) of TumorGraft®
- Multiple tumor types
- Fully characterized and searchable (medical history, genetic, mutations, growth, in vivo drug responses)
- Faithful reconstitution of patient tumor biology in hu-mouse models